Evaluation of existing guidelines for their adequacy for the molecular characterisation and environmental risk assessment of genetically modified plants obtained through synthetic biology.

Commission Directive 2018/350 Commission Implementing Regulation 503/2013 deliberate release environment gene editing genetically modified organisms transgenes

Journal

EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076

Informations de publication

Date de publication:
Feb 2021
Historique:
entrez: 18 2 2021
pubmed: 19 2 2021
medline: 19 2 2021
Statut: epublish

Résumé

Synthetic Biology (SynBio) is an interdisciplinary field at the interface of engineering and biology aiming to develop new biological systems and impart new functions to living cells. EFSA has been asked by the European Commission to evaluate SynBio developments in agri-food with the aim of identifying the adequacy of existing guidelines for risk assessment and determine if updated guidance is needed. The scope of this opinion covers the molecular characterisation and environmental risk assessment of such genetically modified plants obtained through SynBio, meant to be for cultivation or food and feed purposes. The previous work on SynBio by the non-food scientific Committees (2014, 2015) was used and complemented with the output of a horizon scanning exercise, which was commissioned by the EFSA to identify the most realistic and forthcoming SynBio cases of relevance to this remit. The horizon scan did not identify other sectors/advances in addition to the six SynBio categories previously identified by the non-food scientific committees of the European Commission. The exercise did show that plant SynBio products reaching the market in the near future (next decade) are likely to apply SynBio approaches to their development using existing genetic modification and genome editing technologies. In addition, three hypothetical SynBio case studies were selected by the working group of the Panel on Genetically Modified Organisms (GMO), to further support the scoping exercise of this Scientific Opinion. Using the selected cases, the GMO Panel concludes that the requirements of the EU regulatory framework and existing EFSA guidelines are adequate for the risk assessment of SynBio products to be developed in the next 10 years, although specific requirements may not apply to all products. The GMO Panel acknowledges that as SynBio developments evolve, a need may exist to adjust the guidelines to ensure they are adequate and sufficient.

Identifiants

pubmed: 33598046
doi: 10.2903/j.efsa.2021.6301
pii: EFS26301
pmc: PMC7863006
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e06301

Informations de copyright

© 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.

Références

Curr Opin Biotechnol. 2014 Apr;26:62-70
pubmed: 24679260
Plant Biotechnol J. 2018 Apr;16(4):902-910
pubmed: 28921815
J Exp Bot. 2019 Mar 11;70(5):1425-1433
pubmed: 30715460
Metab Eng. 2018 Jul;48:218-232
pubmed: 29890220
Elife. 2019 Sep 19;8:
pubmed: 31535976
J Exp Bot. 2014 May;65(8):1939-46
pubmed: 24687978
Science. 2019 Jan 4;363(6422):
pubmed: 30606819
Transgenic Res. 2016 Dec;25(6):785-793
pubmed: 27520497
Vet Res. 2014 Dec 31;45:117
pubmed: 25559098
Biotechnol J. 2014 Dec;9(12):1526-35
pubmed: 25146562
Trends Biotechnol. 2018 Sep;36(9):898-906
pubmed: 29752192
Annu Rev Plant Biol. 2019 Apr 29;70:667-697
pubmed: 30835493
Bioinformatics. 2014 May 15;30(10):1473-5
pubmed: 24463181
Nat Commun. 2017 Jan 18;8:14261
pubmed: 28098143
Curr Opin Plant Biol. 2014 Jun;19:68-75
pubmed: 24809765
PLoS One. 2016 Jul 25;11(7):e0159934
pubmed: 27454884
Annu Rev Virol. 2018 Sep 29;5(1):453-476
pubmed: 30001182

Auteurs

Classifications MeSH